Cardiac Arrest Treatment Market Growth, Size, Share and Forecast 2020-2026

The global cardiac arrest treatment market is projected to exhibit a significant growth, at a CAGR of around 5.4%, during the forecast period. The rising cases of hypertension or blood pressure around the globe are spurring the growth of the cardiac arrest treatment market. According to the World Health Organization (WHO), approximately 1.13 billion people across the globe suffer from hypertension, in which less than one in five people with hypertension have the problem under control. Hypertension can be a critical cause for premature death across the globe. One of the global targets for noncommunicable diseases is to decrease the pervasiveness of hypertension by 25.0% by 2025.

A full report of Global Cardiac Arrest Treatment Market is available at: https://www.omrglobal.com/industry-reports/cardiac-arrest-treatment-market

Over the past two decades, fatalities due to heart diseases including hypertension have been declining in the developed economies; however, it has been increasing at an alarming rate in emerging economies. Improved access to the individual healthcare interventions along with population-wide measures can result in a significant reduction in the health as well as socioeconomic caused by CVD diseases and their risk factors. At the same time, the healthcare systems in several emerging economies are let down by the model based on the hospital care focused on disease treatment, often centered around the high technology hospitals that offer extensive treatments for only a small group of citizens.

To learn more about this report request a free sample copy @ https://www.omrglobal.com/request-sample/cardiac-arrest-treatment-market

Further, according to the National Center for Biotechnology Information and US National Library of Medicine, hypertension associated deaths are likely to increase from approximately 7.5 million in 2010 to 1.56 billion deaths in 2050, annually across the globe. As per the American Heart Society, in the US in 2017 the fatality rate of hypertension was approximately 9.0% over other CVDs. Heart diseases such as CVD, CHD; among other heart diseases are the leading causes of mortalities across the globe. According to WHO, around 17.9 million fatalities occur each year due to heart diseases, which is estimated to be around 31.0% of the global fatalities. Amongst these fatalities, around 7.4 million had CHD and approx. 6.7 million fatalities occurred due to a stroke.

By 2030, it has been projected that CVDs will be responsible for around 23.6 million mortalities across the globe. Around 80.0% of the deaths caused due to CVD take place in low-middle income group regions, such as Africa, Latin America, and Asia-Pacific. Excessive consumption of alcohol and tobacco, unhealthy diet, and sedentary lifestyle are the major factors that are giving rise to the incidence and prevalence rates of heart diseases. The rapidly increasing prevalence of heart diseases also leads to an alarming number of fatalities around the globe and the trend is expected to continue in the future. Such increasing prevalence of hypertension will further spur the cardiac arrest market during the forecast period.

Global Cardiac Arrest Treatment Market-Segmentation

By Treatment

o Drugs
o Vasopressors
o Corticosteroids
o Anti-arrhythmic Drugs
o Others (Beta blockers and Fibrinolytic drugs)
o Medical Devices
o Defibrillators
o Cardiac Resynchronization Therapy (CRT)
o Others (Ventricular Assist Devices (VADs))

For more customized data, request for report customization @ https://www.omrglobal.com/report-customization/cardiac-arrest-treatment-market

Global Cardiac Arrest Treatment Market- Segment by Region

North America

o United States
o Canada

Europe

o Germany
o United Kingdom
o France
o Spain
o Italy
o Rest of Europe

Asia-Pacific

o China
o Japan
o India
o Rest of Asia-Pacific

Rest of the World

o Middle East & Africa
o Latin America

Company Profiles

o Abbott Laboratories
o AstraZeneca PLC
o Avive Solutions, Inc.
o Boston Scientific Corp.
o Cardiac Science Corp.
o General Electric Co.
o HeartSine Technologies, Ltd.
o Koninklijke Philips N.V.
o Medtronic PLC
o NeuroproteXeon, Inc.
o Pfizer Inc.
o Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
o Stryker Corp.
o WEINMANN Emergency Medical Technology GmbH + Co. KG
o ZOLL Medical Corp.

Media Contact:

Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +1 646-755-7667, +91 7803040404

About Orion Market Research

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

For More Information, Visit https://www.omrglobal.com

This release was published on openPR.